Abstract:
Introduction:
Hypertrophic Cardiomyopathy (HCM) is a disease that involves the myocardium but it is not the result of hypertension or any valvular, congenital, arterial or pericardial abnormalities. 1 Various imaging modalities and electrophysiological study have enhanced our knowledge regarding the systolic and diastolic abnormalities in HCM. Moreover the results of molecular genetic studies have resulted in a quantum leap. 2 Majority of the patients with HCM have at least one other affected first degree relative. It affects males more than females. 3 Mortality rate is approximately 1% per year. 4 Case report: Our patient a 20 year old young man, normotensive, nondiabetic, nonsmoker & nonalcoholic, was admitted in the Coronary Care Unit of Dhaka Medical College Hospital in December, 2012 with the complaints of nonproductive cough and progressively increasing shortness of breath associated with bilateral leg swelling for 15 days. At first his breathlessness occurred in moderate to severe exertion, and it was gradually increasing day by day. It was associated with orthopnoea and paroxysmal nocturnal dyspnoea (PND) and made him bedbound for 7-8 days prior to admission. At the same time, he also noticed abdominal swelling and facial puffiness. He gave history of occasional leg swelling for few months before admission which could be alleviated by taking some medications. Those periods of leg swelling were associated with palpitation and used to last for days to weeks. According to his mother's statement he never played like an average kid during his early childhood and used to retire early while playing. However, he used to perform his daily activities without any trouble. She first noticed his problem when he was unable to walk to nearby school at the age of 7 to 8 years. At that time, he used to experience palpitation, shortness of breath, retrosternal chest discomfort and he needed to take rest for a while before reaching school. Gradually, his problems began to increase and he quit going to school. His elder brother died suddenly at the age of 12 years without any known preceding illness, and so did his father and his grandmother before reaching 40 years of age.
On admission he was dyspnoic (breathing 24 times per minute). Pulse was very feeble, blood pressure was not recordable. JVP was raised to 14 cm H 2 O with a prominent a wave. Apex was shifted to anterior axillary line at left 5 th intercostal space with double apical impulse and it was forceful, sustained. First heart sound was soft, and pulmonary component of the second heart sound was loud. A rough pansystolic murmur of grade 3/ 6 was heard at the apical area with radiation towards axilla and back. An ejection systolic murmur in left lower parasternal area was heard which increased during expiration and squatting. Bilateral basal fine crepitations in both lung fields were found. He had tender hepatomegaly (9 cm). Other systemic examinations were normal. His ECG showed atrial flutter with variable block with heart rate of 70 bpm( 
Fig 1: ECG at admission showing atrial flutter with variable block

Fig.-2: ECG after DC cardioversion
After excluding the presence of any intracardiac thrombus, he was converted to sinus rhythm with immediate DC cardioversion using 50 Joules (Fig 2) .
After DC cardioversion his pulse rate was approximately 60 bpm and blood pressure was 95/ 60 mm Hg. Chest roentgenogram (Fig.3) revealed cardiomegaly. Fig. 7 ). However, there was myocardial bridging with systolic luminal obliteration of left anterior descending artery (LAD) and diagonal (D 1 ) with subsequent diastolic refilling (Fig 8,9 ).
Screening of his family members revealed asymmetrical septal hypertrophy in his younger sister but she was hemodynamically alright and clinically symptomless.
Our diagnosis was congestive cardiac failure and atrial flutter with variable block (reverted to sinus) due to hypertrophic cardiomyopathy with mitral valve prolapse with MR (Grade-II). He was prescribed frusemide, warfarin, spironolactone, propranolol, and amiodarone. Patient's family was informed about the necessity of implanting automated implantable cardioverter defibrillator (AICD), but his family could not afford it. One week after the patient was discharged in a haemodynamically stable condition, his brother informed us that he has had the same miserable destiny just like his brother, father & grandmother i.e. sudden cardiac death.
Discussion:
HCM is characterized by "unexplained LV hypertrophy associated with nondilated LV chamber in the absence of another cardiac or systemic disease (i.e. aortic valve stenosis, systemic hypertension) with or without obstruction to LV outflow tract." 5 It is the most common form of cardiomyopathies which is inherited as autosomal dominant pattern. 5 This is consistent with the pattern of inheritance in our case. HCM is usually recognized by LV wall thickness >15 mm and diagnosis is more presumable if associated with family history of HCM, cardiac symptoms, and ECG finding. 5 Common sites of hypertrophy are septum, LV apex, and LV posterior wall with or without septal involvement. Our case had asymmetrical septal hypertrophy. This occurs with mutation of genes involving beta myosin heavy chain, myosin binding protein C etc. 6 Gross anatomy shows asymmetrical septal hypertrophy, small LV cavity, fibrosis of endocardium, dilated left atrium, and left ventricle outflow tract obstruction by systolic anterior motion of mitral valve. 7 In this case, these were all found except any evidence of LV outflow tract obstruction. Histologically, there is myocardial disarray, and reduced size of septal intramural coronary arteries, 7 which is partly responsible for exercise intolerance. Myocardial ischemia occurs due to supply-demand mismatch & small narrow lumen intramural coronary arteries. Myocardial bridging is frequent in HCM (in this case in LAD and D 1 ) and contributes to increased risk of sudden cardiac death. 2, 5 Diastolic dysfunction is obvious due to high systolic contraction with non-uniform relaxation; resultant increased pulmonary arterial pressure lead to dyspnoea which were also present in this case. 2, 5 Most of the patients are asymptomatic with incidental diagnosis of HCM. Symptomatic ones come with angina, dyspnoea, syncope, palpitation. 2, 5 One of the most important complication is sudden cardiac death (SCD), which may occur either as the first presentation of HCM or may occur at any time in symptomatic patient. Cardiac arrest occurs by asystole, pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), and electromechanical dissociation (EMD). 2, 5 It occurs more in young asymptomatic or less symptomatic patients. 2 Though our patient was symptomatic but strong family history and history of arrhythmia put him in danger zone for SCD.
In precordium double or triple apical impulse, third or fourth heart sounds may be present. An ejection systolic crescendo-decrescendo murmur in left lower parasternal border is heard with radiation to heart base and apex, but not to carotid. Intensity of murmur can be augmented by exercise, and leg raising. 2 ECG shows left ventricular hypertrophy, arrhythmia, pre-excitation, Q wave and ST-T changes. Echocardiography is the gold standard test and left ventricular outflow tract (LVOT) gradient is > 30 mmHg in obstructive variety. In this case, LVOT gradient was normal. Cardiac MRI is superior to echocardiography to provide accurate diagnosis, distribution and extent of HCM. If IHD is suspected then coronary angiogram, MPI, PET, SPECT may be done. 2, 5 Shirley et al. 8 found out that 40-50% of SCD in young patients occurs due to HCM, more with anomalous origin of coronary arteries. Corrado et al. 9 suggested on important congenital causes of SCD in patients less than 35 years old which are mitral-valve prolapse, HCM, and myocardial bridging. Dermengiu et al. 10 reported a case of SCD in a 20 year old athlete without any previous illness due to HCM having both anomalous origin of RCA and myocardial bridging in LAD & LCX at autopsy. Spirito et al. 11 and Alonso et al. 12 So it is rarely used now. AICD is indicated in high risk patients of SCD and has proven mortality benefit. 14 Our patient could not afford it because of financial constrain.
Conclusion:
HCM is the commonest cause of sudden cardiac death in young individuals. Particularly vulnerable ones are with the positive family history of premature death. 5 yearly screening of all first degree relatives are recommended. AICD is the treatment of choice in patients of HCM with risk of SCD.
